Target intelligence / Profile preview

NAD kinase 2, mitochondrial (NADK2)

Target
NADK2
Molecular classification
Enzyme, Kinase
01

Overview

NAD kinase 2, mitochondrial (NADK2) is the dedicated enzyme responsible for the phosphorylation of NAD+ to NADP+ within mitochondria. This reaction supplies the essential pool of mitochondrial NADP(H), supporting antioxidant defense and redox regulation by neutralizing reactive oxygen species, as well as enabling critical biosynthetic pathways such as fatty acid synthesis, cholesterol biosynthesis, lysine degradation, and proline biosynthesis[1][2][3][4]. Unlike cytosolic NADK, NADK2 is structurally distinct, forming non-cooperative dimers rather than tetramers due to the presence of a unique insert domain (EMKA) that alters its oligomerization and regulatory properties[1][2]. Loss-of-function mutations in NADK2 disrupt mitochondrial redox balance, leading to severe multisystem metabolic disorders characterized by neuromuscular impairment, microcephaly, encephalopathy, and lethality in humans[2][3]. NADK2 is thus essential for cellular energy metabolism and mitochondrial integrity.

Other names
C5orf33MNADKNADKD1FLJ30596Mitochondrial NAD kinaseNAD kinase domain-containing protein 1, mitochondrialDECRD
02

Biological functions

Redox homeostasisNADP(H) biosynthesisMitochondrial metabolismAntioxidant defenseFatty acid synthesisLysine degradationCholesterol biosynthesisProline biosynthesis
03

Disease associations

Neurometabolic disordersMicrocephalyNeurodevelopmental delayEncephalopathyOptic atrophyMetabolic disturbances (e.g., hyperlysinemia)Other inherited mitochondrial diseases
04

Safety considerations

Mutations can cause severe mitochondrial and neurological dysfunction, including early lethality, hypotonia, and death in infancy—loss-of-function affects multiple essential metabolic pathways[2][3]
05

Biomarkers

NADK2 deficiency (used to diagnose 2,4-dienoyl-CoA reductase deficiency and secondary metabolic disturbances)

Beyond the preview

Go deeper on NAD kinase 2, mitochondrial (NADK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD kinase 2, mitochondrial (NADK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call